Across
- 5. process of transforming normal cells into malignant cells
- 6. spread of cancer cells from the primary tumor to distant sites
- 7. normal cell mechanism of programmed cell death
- 11. messenger substances that may be released by a cell to create an action at that sire or may be carried by the bloodstream to a distant site before being activated
- 14. field or study of cancer
- 16. donor immune cell response against the malignancy
- 18. abnormally low absolutely neutrophil count
- 19. identification of the type of tissue from which the tumor originated and the degree to which the tumor cells retain the functional and structural characteristics of the tissue of origin
- 22. immune response initiated by T lymphocytes of donor tissues against the recipient’s tissues
- 23. uncontrolled cell growth that follows no physiologic demand; cancer
- 25. using advances in research, technology, and policies to develop individualized plans of care to prevent and treat disease
- 26. group of disorders characterized by abnormal cell proliferation, in which cells ignore growth-regulating signals in the surrounding environment
- 28. inflammation of the oral tissues, often associated with some chemotherapeutic agents and radiation therapy to the head and neck region
- 29. relief of symptoms and promotion of comfort and quality of life regardless of the disease stage
- 32. leakage of intravenous medication from the veins into the subcutaneous tissues
Down
- 1. not cancerous; benign tumors may grow but are unable to spread to other organs or body parts
- 2. use of ionizing radiation to kill malignant cells
- 3. an unfavorable and unintended sign, symptom, or condition associated with cancer treatment
- 4. inflammation of the linig of the mouth, throat, and gastrointestinal tract often associated with cancer therapies
- 6. suppression of the blood cell-producing function of the bone marrow
- 8. use of medications or other agents to kill or prevent the spread of cancer cells by targeting specific part of the cell, with less negative effects on healthy cells
- 9. hair loss
- 10. decrease in the number of circulating platelet; associated with the potential for bleeding
- 12. delivery of radiation therapy through internal implants placed inside or adjacent to the tumor
- 13. process of determining the extent of disease, including tumor size and spread or metastasis to distant sites
- 15. use of medications or other agents to stimulate or suppress components of the immune systems to kill cancer cells
- 17. growth of new blood vessels that allow cancer cells to grow
- 20. substance that can cause inflammation, damage, and necrosis with extravasation from blood vessels and contact with tissues
- 21. use of medications to kill tumor cells by interfering with cellular functions and reproduction
- 24. pattern of growth in which cells lack normal characteristics and differ in shape and organization with respect to their cells of origin; usually, anaplastic cells are malignant
- 27. having cells or processes that are characteristic of cancer
- 30. lowest serum level of blood cells after therapy that has toxic effects on the bone marrow. Describes lowest absolute neutrophil count following chemotherapy
- 31. chemicals, physical factors, and other agents that cause cancer